Engineering a "muco‐trapping" ACE2‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID‐19. - Tiruthani, Karthik; Cruz‐Teran, Carlos; Chan, Jasper F. W.; Ma, Alice; McSweeney, Morgan; Wolf, Whitney; Yuan, Shoufeng; Poon, Vincent K. M.; Chan, Chris C. S.; Botta, Lakshmi; Farrer, Brian; Stewart, Ian; et al. (Bioengineering & Translational Medicine, 2024)